Author

Yinglin Situ

Stanford UniversityORCID 0009-0007-3810-2626Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:machine learning (classical)· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Lei S. QiiD· 2 shared Boxiong Deng· 1 shared Daniel Stauber· 1 shared Jens Peter MagnussoniD· 1 shared Jure LeskoveciD· 1 shared Lorenzo Magni· 1 shared Luna Lyu· 1 shared Maylin L. FuiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

Lei S. QiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioengineeringNature Cell BiologyPeer-reviewedApr 1, 2026

Programmable macromolecule delivery via engineered trogocytosis

Xinyi Chen, Yinglin Situ, Yuexuan Yang…·Lei S. Qi

This study demonstrates a programmable macromolecule delivery system using engineered trogocytosis to transfer proteins between cells, enabling genome editing and targeted cell ablation.

4 citationstop 4%

experimental assaydrug response / drug discovery

𝕏 PostBluesky

Synthetic BiologybioRxivPreprintNov 4, 2024

PreciCE: Precision engineering of cell fates via data-driven multi-gene control of transcriptional networks

Jens Peter Magnusson, Yusuf Roohani, Daniel Stauber…·Lei S. Qi

The paper introduces a method to control cell fates by modulating multiple genes using CRISPR tools and machine learning, demonstrating its effectiveness in stem cell differentiation.

4 citations

humanscRNA-seq

𝕏 PostBluesky